PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18065490-5	2007	Flavopiridol suppressed c-FLIP-l/s and BCL-xL expression, whereas vorinostat reduced expression of BCL-xL, and combined exposure to flavopiridol and vorinostat reduced MCL-1 and X-chromosome-linked inhibitor of apoptosis protein (XIAP) levels.	alvocidib	0-12	BCL2 like 1	Homo sapiens	39-45	
18065490-5	2007	Flavopiridol suppressed c-FLIP-l/s and BCL-xL expression, whereas vorinostat reduced expression of BCL-xL, and combined exposure to flavopiridol and vorinostat reduced MCL-1 and X-chromosome-linked inhibitor of apoptosis protein (XIAP) levels.	alvocidib	132-144	BCL2 like 1	Homo sapiens	39-45	
18065490-9	2007	Flavopiridol suppressed extracellular signal-regulated kinase 1/2 (ERK1/2) and AKT activity and expression of activated forms of AKT and mitogen-activated protein/ERK kinase 1 maintained c-FLIP-l/s, BCL-xL, and XIAP expression and protected cells against flavopiridol/vorinostat lethality.	alvocidib	0-12	BCL2 like 1	Homo sapiens	199-205	
18065490-10	2007	Overexpression of c-FLIP-s and BCL-xL abolished the lethality of flavopiridol/vorinostat.	alvocidib	65-77	BCL2 like 1	Homo sapiens	31-37